Press Room

 

CAPD Statement on PBM Transparency Bills

Today, Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the…

Ahead of Congressional Hearings on Drug Pricing, CAPD Calls on Lawmakers to Address Big Pharma’s Tactics to Delay Competition

Today, Americans are paying high monopoly prices for many of their brand prescription drugs due to a lack…

CAPD Statement on Speaker Pelosi’s Drug Pricing Proposal

Today, Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the…

CAPD Statement on GAO Report Showing PBMs Passed Nearly All Part D Rebates to Plans

Today, Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on a…

New Report Uncovers Big Pharma’s Abuses Cost U.S. Health Care System $31.7 Billion

Report details for the first time the combined impact that Big Pharma’s gamesmanship and many abuses have on…

CAPD Statement on Withdrawal of the Proposed Safe Harbor Rule

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement regarding the reported…

CAPD Statement on Senate HELP Committee Markup on Lower Health Care Costs Act

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement in advance of…

CAPD Letter to the Senate HELP Committee on the Lower Health Care Costs Act of 2019 Discussion Draft